Page last updated: 2024-09-03

dx 9065a and nitroarginine

dx 9065a has been researched along with nitroarginine in 1 studies

Compound Research Comparison

Studies
(dx 9065a)
Trials
(dx 9065a)
Recent Studies (post-2010)
(dx 9065a)
Studies
(nitroarginine)
Trials
(nitroarginine)
Recent Studies (post-2010) (nitroarginine)
92783,93511175

Protein Interaction Comparison

ProteinTaxonomydx 9065a (IC50)nitroarginine (IC50)
Nitric oxide synthase, endothelialBos taurus (cattle)1.2
Nitric oxide synthase, endothelialHomo sapiens (human)0.38
Nitric oxide synthase, brainHomo sapiens (human)1.265
Nitric oxide synthase, brain Rattus norvegicus (Norway rat)4.12
Nitric oxide synthase, inducibleMus musculus (house mouse)0.5
Nitric oxide synthase, inducibleHomo sapiens (human)6.2
Nitric oxide synthase, brainMus musculus (house mouse)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chino, D; Fujita, Y; Ishii, K; Nakayama, K1

Other Studies

1 other study(ies) available for dx 9065a and nitroarginine

ArticleYear
Effects of DX-9065a, an inhibitor of factor Xa, on ellagic acid-induced plantar skin thrombosis assessed in tetrodotoxin- and N(omega)-nitro-L-arginine-treated rats.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:4

    Topics: Animals; Dose-Response Relationship, Drug; Ellagic Acid; Factor Xa Inhibitors; Hindlimb; Male; Naphthalenes; Nitroarginine; Propionates; Rats; Rats, Wistar; Skin; Skin Diseases; Tetrodotoxin; Thrombosis

2003